Paper published in a journal (Scientific congresses and symposiums)
Oral ibandronate (150 mg) continues to be effective and well tolerated when administered monthly: the mobile study long-term extension
Stakkestad, J. A.; Lorenc, R.; Czerwinski, E. et al.
2007In Osteoporosis International, 18 (Suppl.1), p. 135-136
Peer Reviewed verified by ORBi
 

Files


Full Text
P321.pdf
Publisher postprint (239.56 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Endocrinology, metabolism & nutrition
Public health, health care sciences & services
General & internal medicine
Author, co-author :
Stakkestad, J. A.
Lorenc, R.
Czerwinski, E.
Sedarati, F.
Neate, C.
Reginster, Jean-Yves  ;  Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Language :
English
Title :
Oral ibandronate (150 mg) continues to be effective and well tolerated when administered monthly: the mobile study long-term extension
Publication date :
March 2007
Event name :
Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
Event organizer :
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liège, Belgium and ESCEO
Event place :
Porto, Portugal
Event date :
du 28 mars 2007 au 31 mars 2007
Audience :
International
Journal title :
Osteoporosis International
ISSN :
0937-941X
eISSN :
1433-2965
Publisher :
Springer Science & Business Media B.V., Godalming, United Kingdom
Volume :
18
Issue :
Suppl.1
Pages :
S135-136
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 January 2011

Statistics


Number of views
39 (1 by ULiège)
Number of downloads
0 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi